MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14134803

Медицинская библиотека · Journal of clinical medicine · 2025

Impact of RSV Infection in Transplant and Immunocompromised Population: Incidence and Co-Infections: Retrospective Analysis of a Single Centre.

Solidoro Paolo, Curtoni Antonio, Minuto Sara, Shbaklo Nour, De Rosa Francesco Giuseppe, Bondi Alessandro, Sidoti Francesca, Patrucco Filippo, Zanotto Elisa, Corcione Silvia, Boffini Massimo, Marro Matteo, Costa Cristina, Rinaldo Rocco Francesco

СтатьяПеревод в очереди

Аннотация

Respiratory syncytial virus (RSV) represents one of the main respiratory infections found among immunocompromised patients.

Objective

The study analyzes the incidence of RSV infection in different populations of immunocompromised patients as organ transplant recipients (lung, other solid organs, hematopoietic stem cells) and oncologic patients (solid organ malignancy and hematological malignancy) compared to a group of non-immunocompromised patients. We also assessed the prevalence of viral, bacterial, and mycotic coinfection. Moreover, we aimed at evaluating the efficacy of ribavirin treatment in terms of mortality reduction.

Methods

We conducted a retrospective analysis on a total of 466 transplant patients undergoing bronchoscopy with bronchoalveolar lavage for suspected viral disease or surveillance between 2016 and 2023, compared to 460 controls.

Results

The incidence of RSV was significantly higher in immunocompromised patients, particularly in those with lung and bone marrow transplants. Among RSV+ patients, a higher prevalence of viral (influenza virus), bacterial (S. pneumoniae, M. pneumoniae, Nocardia spp.), and fungal (Aspergillus spp.) coinfections were observed. The efficacy of ribavirin in reducing mortality did not show significant differences compared to supportive therapy alone.

Conclusions

The results of our exploratory study suggest that immunocompromised patients are particularly vulnerable to RSV infection and coinfections. Our hypothesis-generating data warrant the need for future studies aimed at exploring preventive and therapeutic strategies for RSV infection in these high-risk patient groups.

Для цитирования: Solidoro Paolo, Curtoni Antonio, Minuto Sara, Shbaklo Nour, De Rosa Francesco Giuseppe, Bondi Alessandro, Sidoti Francesca, Patrucco Filippo, Zanotto Elisa, Corcione Silvia, Boffini Massimo, Marro Matteo, Costa Cristina, Rinaldo Rocco Francesco. Impact of RSV Infection in Transplant and Immunocompromised Population: Incidence and Co-Infections: Retrospective Analysis of a Single Centre.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14134803.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.